FBRX – Forte Biosciences Inc
Float Short %
1.22
Margin Of Safety %
Put/Call OI Ratio
91.5
EPS Next Q Diff
-0.08
EPS Last/This Y
7.74
EPS This/Next Y
1.11
Price
11.54
Target Price
52.25
Analyst Recom
1
Performance Q
51.99
Relative Volume
0.56
Beta
2.68
Ticker: FBRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | FBRX | 11.6 | N/A | N/A | 0 |
| 2025-07-28 | FBRX | 11.87 | 0.00 | 1.20 | 0 |
| 2025-07-29 | FBRX | 10.62 | 0.00 | 1.20 | 0 |
| 2025-07-30 | FBRX | 10.25 | 0.00 | 1.20 | 0 |
| 2025-07-31 | FBRX | 10.09 | 0.00 | 1.20 | 0 |
| 2025-08-01 | FBRX | 9.62 | 1.20 | 999.99 | 11 |
| 2025-08-04 | FBRX | 9.85 | 1.20 | 999.99 | 11 |
| 2025-08-05 | FBRX | 9.7 | 1.20 | 999.99 | 11 |
| 2025-08-06 | FBRX | 10.68 | 1.20 | 999.99 | 11 |
| 2025-08-07 | FBRX | 10.27 | 3.20 | 0.00 | 21 |
| 2025-08-08 | FBRX | 10.23 | 3.20 | 0.00 | 21 |
| 2025-08-11 | FBRX | 10.51 | 4.00 | 999.99 | 20 |
| 2025-08-12 | FBRX | 10.98 | 4.00 | 999.99 | 20 |
| 2025-08-13 | FBRX | 10.73 | 4.00 | 999.99 | 20 |
| 2025-08-14 | FBRX | 10.81 | 4.00 | 999.99 | 20 |
| 2025-08-15 | FBRX | 11.78 | 4.00 | 999.99 | 20 |
| 2025-08-18 | FBRX | 11.92 | 1.50 | 999.99 | 5 |
| 2025-08-19 | FBRX | 11.73 | 41.50 | 999.99 | 85 |
| 2025-08-20 | FBRX | 11.67 | 81.50 | 999.99 | 165 |
| 2025-08-21 | FBRX | 11.11 | 91.50 | 999.99 | 185 |
| 2025-08-22 | FBRX | 11.76 | 91.50 | 999.99 | 185 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | FBRX | 11.60 | 83.6 | - | -4.38 |
| 2025-07-28 | FBRX | 11.89 | 83.6 | - | -4.38 |
| 2025-07-29 | FBRX | 10.66 | 83.6 | - | -4.38 |
| 2025-07-30 | FBRX | 10.19 | 83.6 | - | -4.38 |
| 2025-07-31 | FBRX | 9.98 | 83.6 | - | -4.38 |
| 2025-08-01 | FBRX | 9.61 | 83.6 | - | -4.38 |
| 2025-08-04 | FBRX | 9.79 | 83.6 | - | -4.38 |
| 2025-08-05 | FBRX | 9.70 | 83.6 | - | -4.38 |
| 2025-08-06 | FBRX | 10.73 | 83.6 | - | -4.38 |
| 2025-08-07 | FBRX | 10.30 | 83.6 | - | -4.38 |
| 2025-08-08 | FBRX | 10.18 | 83.6 | - | -4.38 |
| 2025-08-11 | FBRX | 10.49 | 83.6 | - | -4.38 |
| 2025-08-12 | FBRX | 10.86 | 83.6 | - | -4.38 |
| 2025-08-13 | FBRX | 10.57 | 83.6 | - | -4.38 |
| 2025-08-14 | FBRX | 10.82 | 83.6 | - | -4.38 |
| 2025-08-15 | FBRX | 11.68 | 83.6 | - | -4.38 |
| 2025-08-18 | FBRX | 12.05 | 83.6 | - | -4.38 |
| 2025-08-19 | FBRX | 11.75 | 83.6 | - | -4.38 |
| 2025-08-20 | FBRX | 11.68 | 83.6 | - | -4.38 |
| 2025-08-21 | FBRX | 11.29 | 83.6 | - | -4.38 |
| 2025-08-22 | FBRX | 11.54 | 76.5 | - | -4.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-28 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-29 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-30 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-31 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-08-01 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-08-04 | FBRX | 0.00 | 32.42 | 1.16 |
| 2025-08-05 | FBRX | 0.00 | 32.42 | 1.16 |
| 2025-08-06 | FBRX | 0.00 | 32.42 | 1.16 |
| 2025-08-07 | FBRX | 0.00 | 32.42 | 1.16 |
| 2025-08-08 | FBRX | 0.00 | 32.42 | 1.16 |
| 2025-08-11 | FBRX | 0.00 | 32.79 | 1.16 |
| 2025-08-12 | FBRX | 0.00 | 32.79 | 1.17 |
| 2025-08-13 | FBRX | 0.00 | 32.79 | 1.17 |
| 2025-08-14 | FBRX | 0.00 | 32.79 | 1.17 |
| 2025-08-15 | FBRX | 0.00 | 32.79 | 1.17 |
| 2025-08-18 | FBRX | 0.00 | 26.65 | 1.15 |
| 2025-08-19 | FBRX | 0.00 | 26.65 | 1.22 |
| 2025-08-20 | FBRX | 0.00 | 26.65 | 1.22 |
| 2025-08-21 | FBRX | 0.00 | 26.65 | 1.22 |
| 2025-08-22 | FBRX | 0.00 | 26.65 | 1.22 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.96
Avg. EPS Est. Current Quarter
-1.07
Avg. EPS Est. Next Quarter
-1.04
Insider Transactions
Institutional Transactions
26.65
Beta
2.68
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
9
Growth Score
19
Sentiment Score
75
Actual DrawDown %
99.2
Max Drawdown 5-Year %
-99.7
Target Price
52.25
P/E
Forward P/E
PEG
P/S
P/B
1.42
P/Free Cash Flow
EPS
-7.99
Average EPS Est. Cur. Y
-4.43
EPS Next Y. (Est.)
-3.33
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.56
Return on Equity vs Sector %
-67.7
Return on Equity vs Industry %
-54.8
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.05
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 17
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading